CRISPR technology to cure sickle cell disease
High temperatures, remote islands pose challenges for Asian jab distributor
21 January 2021Why healthy food and its local production should be part of the COVID-19 response
21 January 2021CRISPR technology to cure sickle cell disease
University of Illinois Chicago is one of the U.S. sites participating in clinical trials to cure severe red blood congenital diseases such as sickle cell anemia or Thalassemia by safely modifying the DNA of patients’ blood cells.
